| sGC Stimulators |
2023-4-04 |
2023-5-25 |
|
| CRYSTALLINE FORMS OF AN sGC STIMULATOR |
2022-9-28 |
2023-3-30 |
|
| Process for preparing soluble guanylate cyclase stimulators |
2022-9-28 |
2023-4-27 |
|
| TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES WITH sGC STIMULATORS |
2022-8-08 |
2022-10-19 |
|
| Treatment of hfpef in post-menopausal women with an sgc stimulator |
2022-7-28 |
2023-2-02 |
|
| Solid forms of sgc stimulator |
2022-7-04 |
2022-9-06 |
|
| Fused bicyclic scg stimulators |
2022-5-11 |
2022-7-01 |
|
| Treatment of diabetic nephropathy with an sgc stimulator |
2022-4-28 |
2022-7-01 |
|
| Sgc stimulators |
2022-4-19 |
2023-3-01 |
|
| SOLUBLE GUANYLLY CYCLASE (SGC) STIMULATORS |
2022-4-19 |
2023-7-12 |
|
| Treatment of cns diseases with sgc stimulators |
2022-4-19 |
2022-10-27 |
|
| Processes for preparing a compound of formula ib, ic or id; and intermediate … |
2022-4-08 |
2022-10-21 |
|
| Novel process for preparation of soluble guanylate cyclase stimulators |
2022-3-30 |
2022-7-21 |
|
| SGC STIMULATORS |
2022-3-25 |
2023-6-28 |
|
| Solid dispersions comprising a sgc stimulator |
2022-2-03 |
2023-1-01 |
|
| Phosphorus prodrugs of sgc stimulators |
2022-1-26 |
2022-4-19 |
|
| Treatment of cognitive impairment with a cns-penetrant sgc stimulator |
2021-10-12 |
2023-8-23 |
|
| sGC STIMULATORS |
2021-9-27 |
2022-1-20 |
|
| Early drug interventions to reduce covid-19 related respiratory distress, need … |
2021-3-30 |
2021-10-07 |
|
| DEUTERATED sGC STIMULATORS |
2021-3-25 |
2023-4-27 |
|
| USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS |
2021-1-08 |
2021-11-22 |
|
| Pyrazole derivatives as sgc stimulators |
2021-1-07 |
2021-7-22 |
|
| sGC STIMULATORS |
2020-12-15 |
2021-7-15 |
|
| DEUTERATED sGC STIMULATORS |
2020-7-14 |
2021-1-21 |
|
| DEUTERATED sGC STIMULATORS |
2020-7-14 |
2021-1-21 |
|
| Sgc stimulators |
2020-6-19 |
2021-3-22 |
|
| Novel processes for preparation of soluble guanylate cyclase stimulators |
2018-12-27 |
2021-10-31 |
|
| Sgc stimulators |
2018-12-04 |
2019-11-14 |
|
| Treatment of metabolic syndrome with an sGC stimulator |
2018-9-14 |
2022-7-19 |
2022-7-19 |
| USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS |
2017-12-12 |
2019-12-19 |
|
| Fused bicyclic sgc stimulators |
2017-9-01 |
2022-9-30 |
|
| Novel processes for preparation of soluble Guanylate Cyclase stimulators. |
2017-7-06 |
2020-10-23 |
|
| Solid forms of an SGC stimulator. |
2017-7-06 |
2020-10-23 |
|
| Novel processes for preparation of soluble Guanylate Cyclase stimulators. |
2017-7-06 |
2020-10-23 |
|
| USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) |
2017-1-31 |
2018-12-12 |
|
| USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) |
2017-1-31 |
2021-7-06 |
|
| USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER … |
2016-12-13 |
2018-10-24 |
|
| Sgc stimulators |
2016-9-15 |
2017-3-09 |
|
| sGC STIMULATORS |
2016-5-31 |
2017-4-27 |
|
| sGC STIMULATORS |
2016-2-26 |
2016-6-23 |
|
| Sgc stimulators |
2015-9-16 |
2017-7-26 |
|
| Sgc stimulators |
2015-9-16 |
2017-7-26 |
|
| sGC STIMULATORS |
2015-9-16 |
2017-10-19 |
|
| 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators |
2015-8-12 |
2015-12-03 |
|
| Use of sgc stimulators for the treatment of neuromuscular disorders |
2015-1-13 |
2016-11-10 |
|
| sGC STIMULATORS |
2011-3-10 |
2013-7-11 |
|